This disclosure relates to devices and methods for operating on an implantable and inflatable balloon device. More particularly, this disclosure relates to a device and method for providing a proper configuration and orientation for puncturing and aspirating an implantable and inflatable balloon device.
Briefly stated, a deflation device is disclosed according to embodiments, comprising, in combination: an endoscope tube, having a distal end, a proximal end, and a lumen; a cap disposed at the distal end of the endoscope tube and having walls defining a balloon interface chamber; a coring device disposed within the lumen and configured to travel within the lumen such that a distal end of the coring device is extendable beyond the distal end of the cap; and wherein the cap is configured to cause a portion of a surface of a balloon to be orthogonal to a longitudinal axis of the coring device as the coring device is disposed near the distal end of the cap.
The cap may further comprise a flexible distal portion and a rigid proximal portion. The cap may further comprise a protrusion extending radially inward from the walls of the cap, the walls defining a coring channel. The protrusion may be configured to guide the coring device to an orientation perpendicular to the balloon. The protrusion may be an annular ring. The protrusion may be tapered and the coring channel may be a frustoconical space having a proximal aperture smaller than a distal aperture. The protrusion may define a guiding channel for the coring device, wherein the guiding channel may be of a diameter substantially equal to the diameter of the coring device.
The deflation device may further comprise a vacuum device in fluid communication with the balloon interface chamber. The vacuum device may be in fluid communication with the balloon interface chamber via the lumen.
According to embodiments, disclosed is a method for deflating an inflated balloon device, comprising, in combination: advancing a deflation device to a balloon until a cap at a distal end of the deflation device contacts a surface of the balloon, the cap and the surface of the balloon defining a balloon interface chamber; applying a vacuum to the balloon interface chamber, whereby a portion of the surface enclosing the balloon interface chamber is drawn into a convex shape; advancing the coring device from a lumen of the deflation device through a coring channel defined by a protrusion extending radially inward from walls of the cap, whereby a tip of the coring channel is deflected by the protrusion to be made orthogonal to the surface of the balloon at a site of penetration; penetrating the balloon with the coring device at a site of penetration; and aspirating fluid from within the balloon through the site of penetration.
The protrusion may be an annular ring. The protrusion may be tapered and the coring channel may be a frustoconical space having a proximal aperture smaller than a distal aperture. The protrusion may define a guiding channel for the coring device, wherein the guiding channel may be of a diameter substantially equal to the diameter of the coring device. Advancing the coring device within the lumen to the balloon further comprises advancing the coring device against a protrusion extending radially inward from the walls of the cap, whereby the coring device is aligned to be at least substantially orthogonal with a portion of the balloon surface.
According to embodiments, disclosed is a deflation device, comprising, in combination: an endoscope tube, having a distal end, a proximal end, and a lumen; a cap disposed at the distal end of the endoscope tube and having walls defining a balloon interface chamber at a distal end of the cap, the balloon interface chamber being in communication with the lumen; a coring device disposed within the lumen and configured to travel within the lumen such that a distal end of the coring device is extendable beyond the distal end of the cap; a vacuum chamber at the distal end of the cap; and a vacuum line fluidly connected to the vacuum chamber, wherein the vacuum chamber is configured to interface with a surface of a balloon and secure the cap thereto when vacuum pressure is applied.
The vacuum chamber may be an annular ring concentric with the balloon interface chamber. The vacuum chamber may be separated from the balloon interface chamber by a septum.
According to embodiments, disclosed is a method for deflating an inflated balloon device, comprising, in combination: advancing a deflation device to a balloon until a cap of the deflation device contacts a surface of the balloon, whereby a balloon interface chamber and a vacuum chamber of the cap are enclosed partly by the surface of the balloon; providing vacuum to the vacuum chamber, whereby the cap is secured relative to balloon and a portion of the surface enclosing the balloon interface chamber is substantially flat and orthogonal to a longitudinal axis of a coring device within the deflation device; advancing the coring device, whereby the balloon is penetrated at a site of penetration; and aspirating fluid from within the balloon through the site of penetration.
Providing vacuum to the vacuum chamber may be effectuated through a vacuum line in fluid communication with the vacuum chamber. The vacuum chamber may surround the balloon interface chamber. Providing vacuum to the vacuum chamber may cause the portion of the surface enclosing the balloon interface chamber to be stretched flat. Providing vacuum to the vacuum chamber may cause the portion of the surface enclosing the balloon interface chamber to be stretched flat.
The above-mentioned features and objects of the present disclosure will become more apparent with reference to the following description taken in conjunction with the accompanying drawings wherein like reference numerals denote like elements and in which:
Devices for deflation and removal of implantable or inflatable devices are intended to be applied and maintained in a stable and normal fashion to the surface of a balloon wall under stain. By doing so, a full thickness and/or a partial thickness circular cut through the balloon wall is accomplished, reducing the chance for tearing at the coring site, as compared to piercing with a conical, beveled, or facetted needle.
Establishing and maintaining a normal orientation of a coring needle relative to the surface of a balloon to be operated upon may be difficult, as the endoscope catheter used may be flexible and only loosely supported by surrounding anatomy. The balloon may be free to move about and slippery. Both catheter and balloon are subjected to subtle and gross anatomical movement. If the coring needle is not maintained at least substantially orthogonal to the balloon surface, the full thickness and/or a partial thickness cut through the balloon wall may not form the desired complete circle, thereby forming only an incomplete circle. This is not an optimal application of coring for deflation of a balloon under strain, because the terminations or start and ending of the incomplete circle serve as stress risers and can result in small or large tears, corresponding to small or large amounts of undesired fluid leakage from the balloon and an inability to form a seal around the deflation catheter for deflation of the balloon via vacuum.
The inventors of the present disclosure have developed improvements upon devices for deflation of implantable and inflatable devices, such as inflatable intragastric balloons and other medical devices, addressing longstanding needs and avoiding ostensive issues with migration which have plagued clinically relevant devices and methods.
This application incorporates by reference U.S. Pat. Pub. No. 2007/0100368, published May 3, 2007; U.S. Pat. Pub. No. 2007/0100369, published May 3, 2007; U.S. Pat. Pub. No. 2007/0149994, published Jun. 28, 2007; WIPO Pub. No. WO 2007/053556, published Oct. 5, 2007; WIPO Pub. No. WO 2007/053707, published Oct. 5, 2007; WIPO Pub. No. WO 2007/053706, published Oct. 5, 2007; WIPO Pub. No. WO 2007/075810, published May 7, 2007; U.S. patent application Ser. No. 12/723,545, filed on Mar. 12, 2010; PCT App. Ser. No. PCT/US2010/043134, filed on Jul. 23, 2010; each as if fully set forth herein in its entirety.
According to embodiments, the use of endoscopic cap 40 enables the user to normalize a coring needle to balloon surface 110 of balloon 100 and establish a large and stable footprint for puncture at a pre-determined beneficial focal distance, thereby providing the optimal conditions for puncturing the intragastric balloon 100 with a coring needle catheter. The coring needle or other instruments may be delivered to cap 40 via one or more lumens 22 of endoscope 20. Endoscope cap 40 may be attached to the distal tip of endoscope 20, as shown in
As shown in
According to embodiments, contact stability between cap 40 and balloon 100 may be improved by various methods. For example, a user may deflect or retroflex endoscope 20 such that it braces against the nearby gastric wall. By further example, one may provide a high traction engagement surface on cap 40 with a high coefficient of friction material or with surface features such as bumps, indentations, annular rings, or woven fabric to improve contact stability. Further, providing distally extending fingers or projections around the annulus of a distal face of cap 40 may improve contact stability.
According to embodiments, indexing and stability benefits are also achieved by providing endoscopic cap 40 that can apply a vacuum under the whole cap 40 cross-sectional profile or a portion of the profile. As used herein, “vacuum” means a pressure less than at least one of the pressure within balloon 100 and the pressure outside balloon 100, endoscope 20, and cap 40. “Vacuum” refers to providing a pressure that is relatively lower than the pressure of an immediately adjacent space. As used herein, vacuum may not necessarily mean a volume of space that is entirely empty of matter.
According to embodiments, vacuum chamber 50 is provided to interact with surface 110 of balloon 100. As shown in
There are multiple ways in which vacuum may be achieved for improved stability and to hold onto balloon 100. For example, vacuum line 52 may be provided in communication with vacuum chamber 50 of cap 40. Vacuum may be created under all or a portion of cap 40 footprint through independent vacuum line 52 communicating with the cap 40, as shown in
According to embodiments, vacuum may be created under all or a portion of the cap 40 footprint via communication with vacuum applied through the lumen 22 of the endoscope 20. According to embodiments, vacuum may be created under all or a portion of the cap 40 footprint via communication with vacuum applied through a catheter.
When vacuum is applied to an area surrounding the coring needle site, such as around an annular ring, the vacuum may stabilize and hold the balloon surface 110 without deforming or making surface 110 more convex. This leaves the balloon surface 110 substantially flat (or otherwise conforming to portions of cap 40) and generally orthogonal to lumen 22 of endoscope 20 and does not introduce additional stress or strain to the site of penetration.
According to embodiments, vacuum may be applied to balloon interface chamber 60. For example, vacuum may be applied through one or more lumens 22 or through devices therein.
According to embodiments, balloon interface chamber 60 may be configured to cause surface 110 of balloon 100 to conform to the boundaries thereof. For example, as surface 110 of balloon 100 is drawn into balloon interface chamber 60 due to relatively low pressure therein, portions of surface 110 of balloon 100 may conform to the boundaries of balloon interface chamber 60 such as walls 62 or a distal portion of protrusion 46. This may cause surface 110 of balloon 100 to achieve an orthogonal orientation relative to at least one of coring device 30, lumen 22, and endoscope 20.
According to embodiments, when vacuum is applied to an area including the area to be cored, such as balloon interface chamber 60 or the entire area under cap 40, the surface to be cored may be stabilized by the vacuum hold. At the same time, surface 110 may also deform or be made more convex by the applied vacuum. As a result, balloon surface 110 under cap 40 and aligned with the scope working channel may no longer be orthogonal to lumen 22 (i.e., working channel) of endoscope 20 or coring device 30.
A surface having a tendency to deform at the puncture site for the above reasons or others may still be provided with a normal alignment relative to coring device 30 for puncture. For example, endoscopic cap 40 may have one or more protrusions 46 that deflect tip 32 of coring device 30 as it is extended from lumen 22 of endoscope 20 such that it engages the convex portion of surface 110 of balloon 100 at a normal angle of approach. For example, coring device 30 may naturally extend from lumen 22 of endoscope 20 in a manner that does not naturally provide orthogonal alignment any nearby portion of surface 110. This may be the case where coring device 30 and lumen 22 are not aligned on a central axis of the balloon interface chamber 60.
According to embodiments, coring channel 64 may be provided to align coring device 30 as it extends from lumen 22. As shown in
According to embodiments, as shown in
According to embodiments, as shown in
According to embodiments, as shown in
According to embodiments, endoscopic cap 40 may have one or more internal features that partially or completely spans the cross-sectional area of cap 40 and engages balloon surface 110 to ensure that the surface is perpendicular to lumen 22 of endoscope 20. Such features may include a rigid or semi-rigid floor or a flexible septum (preferably clear) with a through hole. Alternatively, there may be provided a lumen within cap 40, struts that extend radially inward, or a mesh extending partially or entirely across cap 40.
According to embodiments, indexing and stability benefits may be achieved by providing endoscopic cap 40 with adhesive on an engagement surface of cap 40. The engagement surface may be the most distal portion of cap 40 or any portion that engages surface 110 of balloon 100. The engagement surface may be the entire cross-sectional area of cap 40 or a portion of the cross-sectional area, such as protrusion 46 as an annular ring. For example, cap 40 may be manufactured with adhesive on the engagement surface (e.g. a pressure sensitive adhesive or an adhesive activated by heat, moisture, chemical, etc.). The user may apply an adhesive to the engagement surface before the balloon puncture procedure. The user may deliver the adhesive, such as a liquid adhesive, to the engagement surface during the balloon puncture procedure. The user may activate the adhesive during the balloon puncture procedure by delivering heat, light, energy, liquid, gas, inter alia.
According to embodiments, endoscope 20 with cap 40 according to features of the present disclosure is shown in the figures. A deflation device may include cap 40 of two or more primary components. For example, cap 40 may include a distal portion manufactured from a rigid polymer (such as polycarbonate), and a proximal portion manufactured from a flexible polymer (such as silicone). The soft section allows for various sizes of endoscopes (8.5 mm to 11 mm, for example) to easily fit within cap 40. Endoscope 20 may be fitted by friction, fixed by adhesive, or otherwise attached to cap 40 (e.g., by threading, notches, snaps, etc.). For example, the soft section may provide a friction fit for holding cap 40 to the distal end of endoscope 20 without damaging the scope. The distal section may be clear to not obstruct the view of the target balloon 100. The distal section includes vacuum chamber 50 as depicted in the figures, according to some embodiments. By utilizing an annular vacuum chamber as vacuum chamber 50, balloon 100 is held relative to the scope and stretched substantially flat without deforming balloon 100 into a convex shape in balloon interface chamber 60.
According to embodiments, coring device 30 may facilitate aspiration by providing a channel therein through which fluid at coring tip 32 may be drawn. Accordingly, coring device 30 may be used to penetrate and subsequently aspirate balloon 100 without the need to withdraw coring device 30. According to embodiments, coring device 30 may include one or more aspiration holes 36 that provide fluid communication between an interior channel of coring device 30 with lumen 22 of endoscope 20. According to embodiments, coring device 30 may be withdrawn from within balloon 100 followed by aspiration of fluid through a site of penetration of coring device 30. Engagement of cap 40 onto balloon 100 may be maintained after withdrawal of coring device 30 and during aspiration of balloon 100.
According to embodiments, a balloon deflation procedure is disclosed for execution with use of cap 40 as disclosed herein. The steps disclosed herein may be performed in any variety of sequences adjustable to the circumstances. The steps may be performed partially or in full, or at different times.
According to embodiments, a patient may be provided with an implanted inflatable balloon 100 ready for deflation or removal. Cap 40 may be provided over a distal tip of endoscope 20. At the doctor's discretion, tape, adhesive, or other interface features may be used to secure cap 40 or vacuum line 52 to the body of endoscope 20.
Endoscope 20 may be delivered to the stomach or other cavity with cap 40 attached. At the doctor's discretion, lubricant may be applied to cap 40 to facilitate delivery. With endoscope 20 straight and in the stomach, coring device 30 may be delivered through lumen 22 of endoscope 20. At the doctor's discretion, lubricant may be applied to coring device 30 beforehand. At this point, the advancement of coring device 30 may be limited to the distal end of endoscope 20 or cap 40, limiting interference as balloon 100 is subsequently engaged by cap 40. Endoscope 20 and cap 40 may be delivered to surface 110 of balloon 100 such that balloon surface 110 is generally perpendicular to endoscope 20 or cap 40. Cap 40 may be pressed onto balloon surface 110.
In some embodiments, suction may be applied through vacuum line 52, lumen 22, or another element, as disclosed herein. Vacuum may be provided to balloon interface chamber 60 or vacuum chamber 50. Devices for providing vacuum suction are known in the field and may be located at a proximal end of endoscope 20 to communicate with the distal end through lumen 22, vacuum line 52, or other channels. The user can confirm that cap 40 has a suction hold of balloon surface 110 by verifying on a suction pump gauge that the vacuum is building. Endoscope 20 position may be adjusted as necessary to achieve a suction hold on balloon surface 110. Endoscope 20 may be secured to maintain the scope's position and stability.
Where vacuum suction is provided to balloon interface chamber 60, a portion of surface 110 defining a portion of balloon interface chamber 60 may be made convex, such that it is drawn into cap 40 and toward endoscope 20. Where vacuum suction is provided to vacuum chamber 50, a portion of surface 110 defining a portion of balloon interface chamber 60 may be secured and stretched flat and substantially orthogonal to coring device 30.
With cap 40 suctioned onto balloon surface 110, coring device 30 may be advanced until its catheter tubing tip 32 lightly touches balloon surface 110. The coring device 30 may be rotated, advanced, or operated in some other fashion to achieve penetration of balloon surface 110 and advancement of coring needle 32. Advancement may be performed to the extent desired. Markings may indicate the amount of advancement achieved for comparison with the amount desired. Retraction of coring needle 32 of coring device 30 may then be effectuated.
Fluid from within balloon 100 may be aspirated through lumen 22 of endoscope 20, a lumen of coring device 30, or some other channel, mechanism, or device. Deflation may be effectuated to any desirable degree. Deflation may occur while coring device 30 is extended or after it is retracted. After balloon 100 is partially or completely deflated, suction through the catheter to secure cap 40 to balloon 100 may be discontinued and the device may be removed from balloon 100.
According to embodiments, a patch may be applied to the penetration site using cap 40. A patch such as a woven material, fabric, rubber, polymer, or elastomer may be carried by cap 40 and placed against balloon surface 110. The patch may have adhesive on the surface facing balloon 100. The adhesive may be applied to the patch as explained above. The patch may be attached to balloon surface 110, creating a reinforced puncture target more resistant to tearing or bursting than a non-reinforced balloon 100.
The steps disclosed herein may be repeated for each balloon where multiple-balloon devices are the object of the procedure. After deflating all or a sufficient number of balloons 100, the deflation device may be removed and the balloon device may be retrieved and removed. At the doctor's discretion, cap 40 may be removed prior to ventilating and/or capturing the balloon device.
According to embodiments, a kit of parts is disclosed. One or more kits of parts can be envisioned by the person skilled in the art, the kits of parts to perform at least one of the methods herein disclosed. Likewise, directions for use (“DFU”) are included and the device may be part of a surgical tray or other packaged accessory set for surgeries. The kit may be a sub-component of a surgical tray.
While the method and agent have been described in terms of what are presently considered to be the most practical and preferred embodiments, it is to be understood that the disclosure need not be limited to the disclosed embodiments. It is intended to cover various modifications and similar arrangements included within the spirit and scope of the claims, the scope of which should be accorded the broadest interpretation so as to encompass all such modifications and similar structures. The present disclosure includes any and all embodiments of the following claims.
It should also be understood that a variety of changes may be made without departing from the essence of the invention. Such changes are also implicitly included in the description. They still fall within the scope of this invention. It should be understood that this disclosure is intended to yield a patent covering numerous aspects of the invention both independently and as an overall system and in both method and apparatus modes.
Further, each of the various elements of the invention and claims may also be achieved in a variety of manners. This disclosure should be understood to encompass each such variation, be it a variation of an embodiment of any apparatus embodiment, a method or process embodiment, or even merely a variation of any element of these.
Particularly, it should be understood that as the disclosure relates to elements of the invention, the words for each element may be expressed by equivalent apparatus terms or method terms—even if only the function or result is the same.
Such equivalent, broader, or even more generic terms should be considered to be encompassed in the description of each element or action. Such terms can be substituted where desired to make explicit the implicitly broad coverage to which this invention is entitled.
It should be understood that all actions may be expressed as a means for taking that action or as an element which causes that action.
Similarly, each physical element disclosed should be understood to encompass a disclosure of the action which that physical element facilitates.
Any patents, publications, or other references mentioned in this application for patent are hereby incorporated by reference. In addition, as to each term used it should be understood that unless its utilization in this application is inconsistent with such interpretation, common dictionary definitions should be understood as incorporated for each term and all definitions, alternative terms, and synonyms such as contained in at least one of a standard technical dictionary recognized by artisans and the Random House Webster's Unabridged Dictionary, latest edition are hereby incorporated by reference.
Finally, all referenced listed in the Information Disclosure Statement or other information statement filed with the application are hereby appended and hereby incorporated by reference; however, as to each of the above, to the extent that such information or statements incorporated by reference might be considered inconsistent with the patenting of this/these invention(s), such statements are expressly not to be considered as made by the applicant(s).
In this regard it should be understood that for practical reasons and so as to avoid adding potentially hundreds of claims, the applicant has presented claims with initial dependencies only.
Support should be understood to exist to the degree required under new matter laws—including but not limited to United States Patent Law 35 USC 132 or other such laws—to permit the addition of any of the various dependencies or other elements presented under one independent claim or concept as dependencies or elements under any other independent claim or concept.
To the extent that insubstantial substitutes are made, to the extent that the applicant did not in fact draft any claim so as to literally encompass any particular embodiment, and to the extent otherwise applicable, the applicant should not be understood to have in any way intended to or actually relinquished such coverage as the applicant simply may not have been able to anticipate all eventualities; one skilled in the art, should not be reasonably expected to have drafted a claim that would have literally encompassed such alternative embodiments.
Further, the use of the transitional phrase “comprising” is used to maintain the “open-end” claims herein, according to traditional claim interpretation. Thus, unless the context requires otherwise, it should be understood that the term “compromise” or variations such as “comprises” or “comprising”, are intended to imply the inclusion of a stated element or step or group of elements or steps but not the exclusion of any other element or step or group of elements or steps.
Such terms should be interpreted in their most expansive forms so as to afford the applicant the broadest coverage legally permissible.
The present application is a U.S. National Phase application under 35 U.S.C. 371 of International Application Serial No. PCT/US2010/050260, filed Sep. 24, 2010, which claims the benefit of U.S. Provisional Patent Application Ser. No. 61/245,630, filed Sep. 24, 2009, and U.S. Provisional Patent Application Ser. No. 61/330,188, filed Apr. 30, 2010, the entire contents of which are incorporated herein by reference in their entireties.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2010/050260 | 9/24/2010 | WO | 00 | 9/21/2012 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2011/038270 | 3/31/2011 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2493326 | Trinder | Jan 1950 | A |
4133315 | Berman et al. | Jan 1979 | A |
4198983 | Becker et al. | Apr 1980 | A |
4246893 | Berson | Jan 1981 | A |
4356824 | Vazquez | Nov 1982 | A |
4416267 | Garren et al. | Nov 1983 | A |
4465072 | Taheri | Aug 1984 | A |
4465818 | Shirahata et al. | Aug 1984 | A |
4485805 | Foster, Jr. et al. | Dec 1984 | A |
4543089 | Moss | Sep 1985 | A |
4598699 | Garren et al. | Jul 1986 | A |
4694827 | Weiner et al. | Sep 1987 | A |
4723547 | Kullas et al. | Feb 1988 | A |
4899747 | Garren et al. | Feb 1990 | A |
4940458 | Cohn | Jul 1990 | A |
5073347 | Garren et al. | Dec 1991 | A |
5084061 | Gau et al. | Jan 1992 | A |
5123840 | Nates | Jun 1992 | A |
5234454 | Bangs | Aug 1993 | A |
5259399 | Brown | Nov 1993 | A |
5263934 | van den Haak | Nov 1993 | A |
5273536 | Savas | Dec 1993 | A |
5318530 | Nelson | Jun 1994 | A |
5334187 | Fischell et al. | Aug 1994 | A |
5431173 | Chin et al. | Jul 1995 | A |
5496271 | Burton et al. | Mar 1996 | A |
5575772 | Lennox | Nov 1996 | A |
5643209 | Fugoso et al. | Jul 1997 | A |
5730722 | Wilk | Mar 1998 | A |
5779728 | Lunsford et al. | Jul 1998 | A |
5857991 | Grothoff et al. | Jan 1999 | A |
5876376 | Schwab et al. | Mar 1999 | A |
5938669 | Klaiber et al. | Aug 1999 | A |
5993473 | Chan | Nov 1999 | A |
5997503 | Willis et al. | Dec 1999 | A |
6149621 | Makihara | Nov 2000 | A |
6254355 | Gharib | Jul 2001 | B1 |
6276567 | Diaz et al. | Aug 2001 | B1 |
6280411 | Lennox | Aug 2001 | B1 |
6423058 | Edwards et al. | Jul 2002 | B1 |
6427089 | Knowlton | Jul 2002 | B1 |
6454785 | De Hoyos Garza | Sep 2002 | B2 |
6524234 | Ouchi | Feb 2003 | B2 |
6535764 | Imran et al. | Mar 2003 | B2 |
6547788 | Maguire et al. | Apr 2003 | B1 |
6579301 | Bales et al. | Jun 2003 | B1 |
6592552 | Schmidt | Jul 2003 | B1 |
6613018 | Bagga et al. | Sep 2003 | B2 |
6613037 | Khosravi et al. | Sep 2003 | B2 |
6706010 | Miki et al. | Mar 2004 | B1 |
6746460 | Gannoe et al. | Jun 2004 | B2 |
6826428 | Chen et al. | Nov 2004 | B1 |
6850128 | Park | Feb 2005 | B2 |
6866657 | Shchervinsky et al. | Mar 2005 | B2 |
6869431 | Maguire et al. | Mar 2005 | B2 |
6890300 | Lloyd et al. | May 2005 | B2 |
6890346 | Ganz et al. | May 2005 | B2 |
6902535 | Eberhart et al. | Jun 2005 | B2 |
6923754 | Lubock | Aug 2005 | B2 |
6931286 | Sigg et al. | Aug 2005 | B2 |
6939299 | Petersen et al. | Sep 2005 | B1 |
6958052 | Charlton | Oct 2005 | B1 |
7001419 | DiCapino et al. | Feb 2006 | B2 |
7016735 | Imran et al. | Mar 2006 | B2 |
7020531 | Colliou et al. | Mar 2006 | B1 |
7033373 | De la Torre et al. | Apr 2006 | B2 |
7056305 | Garza Alvarez | Jun 2006 | B2 |
7076305 | Imran et al. | Jul 2006 | B2 |
7081125 | Edwards et al. | Jul 2006 | B2 |
7131945 | Fink et al. | Nov 2006 | B2 |
7483746 | Lee et al. | Jan 2009 | B2 |
7625355 | Yu | Dec 2009 | B2 |
7828749 | Douglas et al. | Nov 2010 | B2 |
8083757 | Gannoe et al. | Dec 2011 | B2 |
20010022988 | Schwarz et al. | Sep 2001 | A1 |
20010037127 | De Hoyos Garza | Nov 2001 | A1 |
20020055757 | Torre | May 2002 | A1 |
20020107515 | Edwards et al. | Aug 2002 | A1 |
20020161388 | Samuels et al. | Oct 2002 | A1 |
20020173804 | Rousseau | Nov 2002 | A1 |
20030114878 | Diederich et al. | Jun 2003 | A1 |
20030171768 | McGhan | Sep 2003 | A1 |
20030187390 | Bates et al. | Oct 2003 | A1 |
20040044354 | Gannoe et al. | Mar 2004 | A1 |
20040059289 | Garva Alvarez | Mar 2004 | A1 |
20040059290 | Palasis | Mar 2004 | A1 |
20040073162 | Bleam et al. | Apr 2004 | A1 |
20040087902 | Richter | May 2004 | A1 |
20040106899 | McMichael et al. | Jun 2004 | A1 |
20040116897 | Aboul-Hosn | Jun 2004 | A1 |
20040127915 | Fleenor et al. | Jul 2004 | A1 |
20040186502 | Sampson et al. | Sep 2004 | A1 |
20040220665 | Hossainy | Nov 2004 | A1 |
20040236280 | Rice et al. | Nov 2004 | A1 |
20040236361 | Sakurai | Nov 2004 | A1 |
20040254600 | Zarbatany et al. | Dec 2004 | A1 |
20050027283 | Richard et al. | Feb 2005 | A1 |
20050027313 | Shaker | Feb 2005 | A1 |
20050038415 | Rohr et al. | Feb 2005 | A1 |
20050055039 | Burnett et al. | Mar 2005 | A1 |
20050059990 | Ayala | Mar 2005 | A1 |
20050075624 | Miesel | Apr 2005 | A1 |
20050085792 | Gershowitz | Apr 2005 | A1 |
20050119674 | Gingras et al. | Jun 2005 | A1 |
20050131442 | Yachia et al. | Jun 2005 | A1 |
20050143784 | Imran | Jun 2005 | A1 |
20050159769 | Alverdy | Jul 2005 | A1 |
20050177103 | Hunter et al. | Aug 2005 | A1 |
20050192615 | Torre et al. | Sep 2005 | A1 |
20050267595 | Chen et al. | Dec 2005 | A1 |
20050267596 | Chen et al. | Dec 2005 | A1 |
20050273060 | Levy et al. | Dec 2005 | A1 |
20060058829 | Sampson et al. | Mar 2006 | A1 |
20060178691 | Binmoeller | Aug 2006 | A1 |
20060184112 | Horn et al. | Aug 2006 | A1 |
20060259020 | Sharratt | Nov 2006 | A1 |
20070016262 | Gross et al. | Jan 2007 | A1 |
20070093728 | Douglas et al. | Apr 2007 | A1 |
20070100367 | Quijano | May 2007 | A1 |
20070100368 | Quijano | May 2007 | A1 |
20070100369 | Cragg | May 2007 | A1 |
20070142770 | Rioux et al. | Jun 2007 | A1 |
20070149994 | Sosnowski | Jun 2007 | A1 |
20070173881 | Birk et al. | Jul 2007 | A1 |
20070233161 | Weller et al. | Oct 2007 | A1 |
20070250020 | Kim et al. | Oct 2007 | A1 |
20070265369 | Muratoglu et al. | Nov 2007 | A1 |
20070265598 | Karasik | Nov 2007 | A1 |
20070288033 | Murature et al. | Dec 2007 | A1 |
20080058887 | Griffin et al. | Mar 2008 | A1 |
20080082056 | Mauch et al. | Apr 2008 | A1 |
20080097513 | Kaji et al. | Apr 2008 | A1 |
20080119729 | Copa et al. | May 2008 | A1 |
20080172079 | Birk | Jul 2008 | A1 |
20080190363 | Chen et al. | Aug 2008 | A1 |
20080208241 | Weiner et al. | Aug 2008 | A1 |
20080233167 | Li et al. | Sep 2008 | A1 |
20080243071 | Quijano | Oct 2008 | A1 |
20080243166 | Paganon et al. | Oct 2008 | A1 |
20080255601 | Birk | Oct 2008 | A1 |
20080319471 | Sosnowski et al. | Dec 2008 | A1 |
20090048624 | Alverdy | Feb 2009 | A1 |
20090275973 | Chen et al. | Nov 2009 | A1 |
20100023047 | Simpson | Jan 2010 | A1 |
20100130998 | Alverdy | May 2010 | A1 |
20100243135 | Pepper et al. | Sep 2010 | A1 |
20100251837 | Bouasaysy et al. | Oct 2010 | A1 |
20110178544 | Sosnowski et al. | Jul 2011 | A1 |
20120271336 | Hamman et al. | Oct 2012 | A1 |
20120289992 | Quijano et al. | Nov 2012 | A1 |
Number | Date | Country |
---|---|---|
8708978 | Nov 1987 | DE |
0103481 | Mar 1984 | EP |
0457456 | May 1990 | EP |
0485903 | Aug 1991 | EP |
1781183 | May 2007 | EP |
2862525 | May 2005 | FR |
2139902 | Nov 1984 | GB |
S57168674 | Oct 1982 | JP |
S6415063 | Jan 1989 | JP |
H091872 | Apr 1989 | JP |
H08322943 | Dec 1996 | JP |
2001128985 | May 2001 | JP |
2006333888 | Dec 2006 | JP |
WO-0141700 | Jun 2001 | WO |
WO-0166166 | Sep 2001 | WO |
WO2006035446 | Apr 2006 | WO |
WO-2006056944 | Jun 2006 | WO |
WO2006128978 | Dec 2006 | WO |
WO-2007053556 | May 2007 | WO |
WO-2007053706 | May 2007 | WO |
WO-2007053707 | May 2007 | WO |
WO-2007075810 | Jul 2007 | WO |
WO-2008042819 | Apr 2008 | WO |
WO-2008121831 | Oct 2008 | WO |
WO-2007027812 | Apr 2009 | WO |
WO-2009055386 | Apr 2009 | WO |
WO2009112786 | Sep 2009 | WO |
WO-2010048021 | Apr 2010 | WO |
WO2010115161 | Oct 2010 | WO |
WO2011011629 | Jan 2011 | WO |
WO2011011741 | Jan 2011 | WO |
WO2011011743 | Jan 2011 | WO |
WO2011038270 | Mar 2011 | WO |
WO2011024077 | Aug 2011 | WO |
WO2011097637 | Aug 2011 | WO |
WO2011127205 | Oct 2011 | WO |
WO2012048226 | Apr 2012 | WO |
Entry |
---|
Non-Final Office Action; U.S. Appl. No. 11/263,302; dated: Oct. 9, 2012, 6 pages. |
Non-Final Office Action; U.S. Appl. No. 12/625,473; dated Jul. 12, 2012; 10 pages. |
Non Final Office Action; U.S. Appl. No. 12/753,751; dated Oct. 5, 2012, 8 pages. |
Non-Final Office Action; U.S. Appl. No. 13/074,956; dated Oct. 1, 2012, 8pages. |
Wahlen CH et al. “The BioEnterics Intragastric Balloon: How to use it” Obesity Surgery 2001; 11:524-527. |
European Supplementary Search Report; EP Application No. 10802994.3, Applicant: ReShape Medical, Inc., mailed Jun. 28, 2013, 8 pgs. |
European Supplementary Search Report; EP Application No. 10802918.2, Applicant: ReShape Medical, Inc., mailed Jun. 5, 2013, 6 pgs. |
European Search Report—Supplementary; EP 03726447.0, Applicant: Applied Medical Resources Corporation: Mar. 1, 2006, 3 pgs. |
Final Office Action; U.S. Appl. No. 11/694,536, Mailing Date Mar. 11, 2011, 13 pages. |
Final Office Action; U.S. Appl. No. 11/768,152, Mailing Date Jan. 19, 2011, 13 pages. |
International Search Report; International Application No. PCT/US2010/042948; Applicant: ReShape Medical, Inc., Mailing Date Apr. 1, 2011, 11 pages. |
International Search Report; International Application No. PCT/US2010/043134; Applicant: ReShape Medical, Inc., Mailing Date Apr. 27, 2011, 12 pages. |
International Search Report; International Application No. PCT/US2010/043136; Applicant: ReShape Medical, Inc., Mailing Date Apr. 12, 2011, 9 pages. |
International Search Report; International Application No. PCT/US2010/050260; Applicant: ReShape Medical, Inc., Mailing Date: Jun. 17, 2011, 9 pages. |
International Search Report; International Application No. PCT/US2011/026233; Applicant: ReShape Medical, Inc., Mailing Date Apr. 26, 2011, 9 pages. |
International Search Report; International Application No. PCT/US2011/031463; Applicant: ReShape Medical, Inc., Mailing Date: Jun. 27, 2011, 10 pages. |
International Search Report; International Application No. PCT/US2003/012782, Applicant: Applied Medical Resources Corporation, dated: Oct. 28, 2003, 7 pages. |
International Search Report; International Application No. PCT/US2006/042336, Applicant: Abdominus, Inc., dated: Mar. 14, 2007, 9 pages. |
International Search Report; International Application No. PCT/US2006/042710, Applicant: Abdominus, Inc. et al., dated: Mar. 15, 2007, 9 pages. |
International Search Report; International Application No. PCT/US2006/042711, Applicant: Abdominus, Inc. et al, dated: Mar. 16, 2007, 9 pages. |
International Search Report; International Application No. PCT/US2006/048647, Applicant: Abdominus, Inc. et al., dated: May 22, 2007, 12 pages. |
International Search Report; International Application No. PCT/US2008/058677, Applicant: ReShape Medical et al., dated: Aug. 21, 2008, 12 pages. |
International Search Report; International Application No. PCT/US2008/068058, Applicant: ReShape Medical, Inc. et al, dated: Nov. 19, 2008, 11 pages. |
International Search Report; International Application No. PCT/US2010/029865, Applicant: ReShape Medical, Inc., dated: Jan. 5, 2011, 9 pages. |
International Search Report; International Application No. PCT/US2011/024077; Applicant: ReShape Medical, Inc., dated: Apr. 6, 2011, 12 pages. |
International Search Report; International Application No. PCT/US2011/024082, Applicant: ReShape Medical, Inc., dated: Apr. 6, 2011, 10 pages. |
International Search Report; International Application No. PCT/US1155373, Applicant: Reshape Medical, Inc., dated: Jan. 20, 2012, 7 pages. |
“Living with the BIB: BioEnterics Intragastric Balloon Program: Patient Information”; INAMED Health: Bioenteris Corporation, ECO-SBA-10434; dated Apr. 20, 2004 and May 14, 2005, located online at: www.sydneyobesity.com.au/pdf/M946-01.pdf; 10 pages. |
Non-Final Office Action; U.S. Appl. No. 11/694,536; dated: Oct. 26, 2011, 13 pages. |
Non-Final Office Action; U.S. Appl. No. 12/625,473; dated Oct. 24, 2011, 18 pages. |
Non-Final Office Action; U.S. Appl. No. 12/723,545; dated Feb. 29, 2012, 10 pages. |
“ReShape Inflatable Gastric Balloon Going on Trial as Weight Loss Option,” MedGadget: Internet Journal of Emerging Medical Technologies. Feb. 4, 2010, 5 pages. |
Extended European Search Report; Application No. EP11766679.2, Applicant: Reshape Medical, Inc., mailed Dec. 12, 2013, 6 pages. |
Extended European Search Report; Application No. EP11748141.6, Applicant: Reshape Medical, Inc., mailed Feb. 25, 2014, 6 pages. |
Final Office Action; U.S. Appl. No. 13/858,767, Mailing Date May 22, 2013, 12 pages. |
Extended European Search Report; Application EP11740536.5, Applicant: ReShape Medical, Inc., mailed Jul. 3, 2014, 8 pages. |
Extended European Search Report; Application EP11831683.5, Applicant: Reshape Medical, Inc., mailed Jul. 3, 2014, 8 pages. |
Final Office Action; U.S. Appl. No. 13/556,0-32, mailed on Jan. 28, 2014, 8 pages. |
Non-Final Office Action; U.S. Appl. No. 13/386,650: mailed on Jun. 3, 2014, 15 pages. |
Notice of Allowance; U.S. Appl. No. 12/753,603, dated May 13, 2014, 18 pages. |
Ostrovsky, ReShape Inflatable Gastric Balloon going on Trial as Weight Loss Option; http://www.medgadget.com/2010/02/reshape—inflatable—gastric—balloon—system—going—on—trial—as—L wieight—loss—option.html Feb. 4, 2010, retrieved on 02-10-2-13. |
Number | Date | Country | |
---|---|---|---|
20130066267 A1 | Mar 2013 | US |
Number | Date | Country | |
---|---|---|---|
61245630 | Sep 2009 | US | |
61330188 | Apr 2010 | US |